The process for Class III medical device registration with Brazil's ANVISA (National Health Surveillance Agency) involves a series of steps to ensure that the device meets all safety, performance, and regulatory standards required for commercialization in Brazil. Below is a detailed overview of the steps involved in the registration process:

1. Classification of the Medical Device

Before starting the registration process, it is essential to classify the device. Class III medical devices are those that present a high risk to patients or users, such as implantable devices, heart valves, pacemakers, etc. ANVISA classifies devices based on their risk to health and the complexity of their intended use.

• Class III devices require the most stringent evaluation by ANVISA, including full technical documentation and clinical data.

2. Appoint a Local Authorized Representative

If you are a foreign manufacturer, you must appoint a local authorized representative in Brazil who will act as the point of contact for ANVISA and manage regulatory communication on your behalf.

• This representative is responsible for submitting applications, handling correspondence, and ensuring compliance with local regulations.

3. Prepare Required Documentation

For Class III medical devices, the documentation required is extensive and includes:

a) Technical File

The technical file contains detailed information about the device, including:

• Device description (intended use, design, materials used, etc.)
• Device labeling and packaging (must comply with Brazilian language and content requirements)
• Risk analysis (including risk management documentation following ISO 14971)
• Clinical evidence (clinical trials, post-market surveillance data, or scientific literature that supports the safety and efficacy of the device)
• Device specifications and performance data
• Instructions for use (IFU)

b) Quality Management System (QMS)

Class III devices must be manufactured under a compliant Quality Management System, such as ISO 13485. Documentation proving compliance with QMS must be submitted, including:

• Evidence of ISO 13485 certification or equivalent (if applicable).
• Manufacturing and sterilization processes.
• Inspection and testing procedures.

c) Clinical Data and Evidence

Class III devices require clinical data that demonstrates the safety and efficacy of the device. This can include:

• Clinical studies or trials conducted on the device.
• Post-market clinical follow-up data if the device is already marketed in other countries.

d) Risk Management

Submit a risk management plan that evaluates potential risks associated with the device and the measures in place to mitigate them. This must be consistent with international standards such as ISO 14971.

4. Submit the Registration Application

Once the documentation is prepared, you need to submit the application to ANVISA. This is done through the Sistema de Peticionamento Eletrônico (SIP), which is the online system for regulatory submissions in Brazil.

• Application submission should include:
  • All required documentation (technical file, clinical data, QMS, risk management reports).
  • Boleto Bancário (Bank slip) for payment of registration fees.
  • Any additional forms required by ANVISA, such as a statement confirming the appointment of a local representative.

5. Payment of Registration Fees

A fee must be paid to ANVISA to process the registration application. The amount varies depending on the complexity of the device and the type of application.

• Payment is made via Boleto Bancário, which is a payment slip used for transactions in Brazil.

6. ANVISA Evaluation of the Application

Once the application is submitted, ANVISA will review the provided documents to ensure they meet regulatory requirements.

• Evaluation process typically involves:
  • Checking the technical documentation for completeness and compliance.
  • Assessing the clinical evidence and risk management information.
  • Verifying that the device complies with Brazilian regulations for medical devices (RDC 185/2001, RDC 510/2021, etc.).
  • In some cases, ANVISA may request additional information or clarification regarding the device’s safety, efficacy, or manufacturing process.

7. Inspection (If Applicable)

For Class III devices, ANVISA may require an inspection of the manufacturing facility to ensure compliance with Good Manufacturing Practices (GMP).

• If the device is being imported, the manufacturing facility must be registered, and the processes should comply with international quality standards (such as ISO 13485).
• In cases where the manufacturing process involves electrical components or sterilization, INMETRO certification may also be required.

8. Issuance of the Registration Certificate

If ANVISA finds the submission complete and compliant, it will issue the registration certificate for the Class III medical device.

• The registration certificate allows the device to be marketed and sold in Brazil.
• The certificate will list the approved indications for the device, as well as any specific regulatory conditions.

9. Post-Market Obligations

After registration, the manufacturer or authorized representative must comply with ongoing post-market obligations:

• Post-market surveillance: Continuous monitoring of the device’s safety and performance, including reporting adverse events and taking corrective actions if necessary.
• Periodic renewal: Class III medical device registration must be renewed every 5 years, which involves submitting updated documentation to ANVISA.
• Adverse event reporting: Manufacturers must report any serious adverse events or product defects to ANVISA as part of a vigilance system.
• Field safety corrective actions (FSCA): If necessary, the device may need to be recalled or corrected if safety issues arise.

10. Ongoing Compliance and Inspections

ANVISA may periodically inspect the manufacturing facilities or conduct audits to ensure continued compliance with regulatory requirements and Good Manufacturing Practices (GMP).

Summary of Steps for Class III Medical Device Registration with ANVISA

1. Classify the Device: Ensure the device is correctly classified as Class III based on its risk level.
2. Appoint a Local Authorized Representative: If the manufacturer is outside Brazil, designate a local representative to handle communications.
3. Prepare Documentation: Include technical documentation, clinical data, risk management plan, QMS evidence, labeling, and post-market surveillance information.
4. Submit the Application: Submit the application through ANVISA's online portal (SIP), along with payment of fees.
5. Evaluation by ANVISA: ANVISA reviews the application and may request additional information.
6. Inspection (if required): If needed, ANVISA may conduct inspections of the manufacturing facility.
7. Receive Registration Certificate: Upon approval, ANVISA issues a registration certificate.
8. Post-Market Surveillance: Follow post-market requirements, including monitoring the device’s performance, reporting adverse events, and renewing the registration every five years.

By following these steps and ensuring that all regulatory requirements are met, you can successfully navigate the Class III medical device registration process with Brazil's ANVISA.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn